Series A - D3 Bio
Investment Firm
Overview
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
Announced Date
Apr 08, 2024
Closed on Date
Apr 08, 2024
Funding Type
Series A
Highlights
Location
Asia
Social
Participant Investors
2
| Investor Name |
|---|
 Medicxi |
 Matrix Partners China |
Round Details and Background
D3 Bio raised $62000000 on 2024-04-08 in Series A
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 17, 2020 |  Series A - D3 Bio | 5 | - | 200.0M |
| Apr 08, 2024 | Series A - D3 Bio | 3 | - | 62.0M |
Recent Activity
There is no recent news or activity for this profile.